June 07, 2023

Jack Lifton on Appia Rare Earths’ Brazilian Acquisition and the Critical Minerals Institute Summit

, ,

In this InvestorIntel interview, Tracy Weslosky talks with Critical Minerals Institute’s (CMI) Co-Chairman Jack Lifton about why Appia Rare Earths & Uranium Corp.’s (CSE: API | OTCQX: APAAF) acquisition of a Brazilian rare earths ionic clay project, if finalized, will be an “intelligent vertical integration by Appia.”

Speaking about Appia’s Alces Lake Project as a “premier deposit of neodymium-rich monazite in North America,” Jack explains how the new Brazilian project will be synergistic with the Alces Lake Project. Jack discusses how the new Brazilian project can be a low radiation source of critical heavy rare earths such as dysprosium and terbium.

Speaking about the upcoming Critical Minerals Institute Summit II (CMI Summit II) to be held in Toronto on June 14-15, 2023, Jack discusses that he intends to address if the North American industry can become self-sufficient in critical minerals. He goes on to discuss how the shortage of experienced competent mining engineers, in some ways, is a bigger problem for the Western world than the supply of critical minerals.

To access the full episode, click here.

Subscribe to the InvestorIntel YouTube channel by clicking here.

About The Critical Minerals Institute

The Critical Minerals Institute or CMI is an international organization for critical mineral companies and professionals focused on battery and technology materials, defense metals, and ESG technologies in the EV market. Offering a wide range of B2B service solutions, the Critical Minerals Institute hosts both online and in-person events designed for education, collaboration, and service solutions that address critical mineral challenges for a decarbonized economy.

To learn more about The Critical Minerals Institute, click here.

Disclaimer: The author of this post may or may not be a shareholder of any of the companies mentioned in this column. None of the companies discussed in the above feature have paid for this content. The writer of this article/post/column/opinion is not an investment advisor, and is neither licensed to nor is making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence. To access the InvestorIntel.com disclaimer and other important legal notices, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *